MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
AtriCure Cash and Cash Equivalents 2011-2025 | ATRC
Annual Cash and Cash Equivalents AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123 M | 84.3 M | 58.1 M | 43.7 M | 41.9 M | 28.5 M | 32.2 M | 21.8 M | 24.2 M | 23.8 M | 28.4 M | 14.9 M | 7.75 M | 9.76 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 123 M | 7.75 M | 38.7 M |
Quarterly Cash and Cash Equivalents AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118 M | 99.9 M | 123 M | 130 M | 106 M | 65 M | 84.3 M | 80.6 M | 67.2 M | 77.3 M | 58.1 M | 48.8 M | 54.6 M | 28.1 M | 43.7 M | 39.9 M | 67.6 M | 85.4 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 24.2 M | 24.2 M | 24.2 M | 24.2 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 28.4 M | 28.4 M | 28.4 M | 28.4 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 7.75 M | 7.75 M | 7.75 M | 7.75 M | 9.76 M | 9.76 M | 9.76 M | 9.76 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 130 M | 7.75 M | 39.8 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
1.76 B | $ 19.3 | 0.26 % | $ 9.84 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 195.64 | 0.25 % | $ 56.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
6.49 M | $ 10.58 | 93.77 % | $ 213 M | USA |
 |
Harvard Bioscience
HBIO
|
4.28 M | $ 0.66 | -0.66 % | $ 28 M | USA |
 |
Repro Med Systems
KRMD
|
11.5 M | $ 5.69 | -6.11 % | $ 259 M | USA |
 |
LeMaitre Vascular
LMAT
|
25.6 M | $ 83.01 | 0.06 % | $ 1.86 B | USA |
 |
Alcon
ALC
|
1.68 B | $ 79.31 | -1.29 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
178 M | $ 131.07 | 0.19 % | $ 6.99 B | USA |
 |
iRhythm Technologies
IRTC
|
420 M | $ 178.57 | -0.02 % | $ 5.57 B | USA |
 |
Merit Medical Systems
MMSI
|
377 M | $ 88.56 | 0.39 % | $ 5.16 B | USA |
 |
ICU Medical
ICUI
|
309 M | $ 144.63 | -1.77 % | $ 3.53 B | USA |
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
10.3 M | $ 4.65 | -2.52 % | $ 25.6 K | USA |
 |
Isoray
ISR
|
61.6 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 13.0 | 1.01 % | $ 531 M | USA |
 |
OraSure Technologies
OSUR
|
268 M | $ 2.47 | 1.65 % | $ 184 M | USA |
 |
The Cooper Companies
COO
|
111 M | $ 82.47 | 0.33 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 114.24 | -1.13 % | $ 5.53 B | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 80.98 | 0.56 % | $ 4.08 B | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 8.91 | -0.56 % | $ 184 M | USA |
 |
STERIS plc
STE
|
172 M | $ 255.47 | -0.29 % | $ 25.2 B | USA |
 |
Intuitive Surgical
ISRG
|
2.03 B | $ 572.63 | -0.48 % | $ 203 B | USA |
 |
ResMed
RMD
|
274 M | $ 243.08 | 0.09 % | $ 35.5 B | USA |
 |
Microbot Medical
MBOT
|
2.47 M | $ 2.05 | -2.84 % | $ 20.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
3.26 M | $ 0.27 | -5.66 % | $ 21.5 M | USA |
 |
Nephros
NEPH
|
4.31 M | $ 4.72 | -3.08 % | $ 49 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.07 B | $ 21.91 | 0.46 % | $ 3.77 B | USA |
 |
Predictive Oncology
POAI
|
735 K | - | - | $ 32.4 M | USA |
 |
Utah Medical Products
UTMD
|
92.9 M | $ 56.28 | -1.52 % | $ 204 M | USA |
 |
Stereotaxis
STXS
|
19.8 M | $ 2.29 | -0.43 % | $ 185 M | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 38.6 | -2.14 % | $ 127 M | USA |
 |
Pulse Biosciences
PLSE
|
44.4 M | $ 13.7 | -3.18 % | $ 658 M | USA |
 |
Repligen Corporation
RGEN
|
751 M | $ 166.59 | 0.52 % | $ 9.28 M | USA |
 |
BioLife Solutions
BLFS
|
95.4 M | $ 24.66 | -1.83 % | $ 1.14 B | USA |
 |
Retractable Technologies
RVP
|
4.24 M | $ 0.78 | -4.3 % | $ 23.4 M | USA |
 |
STAAR Surgical Company
STAA
|
144 M | $ 23.21 | -0.73 % | $ 1.14 B | USA |
 |
Teleflex Incorporated
TFX
|
290 M | $ 121.62 | -0.93 % | $ 5.7 B | USA |
 |
West Pharmaceutical Services
WST
|
485 M | $ 276.87 | 0.46 % | $ 20.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
272 M | $ 11.4 | 1.33 % | $ 2.32 B | USA |